Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094781 · ClinicalTrials.gov registry record · Phase 1
Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males
A Phase 1 study of Nutritional Status, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02094781: Completed Phase 1 study of Nutritional Status, sponsored by GlaxoSmithKline.
NCT02094781 is a Phase 1 study of Nutritional Status that has completed, run by GlaxoSmithKline. The registered enrollment target is 18 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02094781, a Phase 1 study of Nutritional Status, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper and lower body strength.
Primary Outcome
Body strength will be evaluated using Repetition maximum (1-RM) and bench and leg press exercise testing. 1-RM in weight training is the maximum amount of weight one can lift in a single repetition for a given exercise
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whey protein and creatine supplement
- DIETARY_SUPPLEMENT Whey protein only supplement
Study Locations (1)
Florida
- GSK Investigational Site - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
What the finished NCT02094781 record still lists
NCT02094781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Nutritional Status appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02094781 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02094781 about?
NCT02094781 is a clinical study titled "Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males". The purpose of this study was to evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper and lower body strength.
What is the current status of trial NCT02094781?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2013-12. Estimated completion is 2014-09.
What conditions does trial NCT02094781 study?
This clinical trial studies the following conditions: Nutritional Status.
What interventions are being tested in trial NCT02094781?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whey protein and creatine supplement (DIETARY_SUPPLEMENT), Whey protein only supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02094781?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02094781 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nutritional Status
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02094781's enrollment target sits among peer trials
18 1720th of 2000 higher than 216 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia